Jack shares how living with Stargardt disease informs his work as an entrepreneur. Learn more about Jack’s inspiring story: https://lnkd.in/eHygrpDu #stargardt #AlkeusPharma #inspiration #YourNorthStarg #patientvoices
Alkeus Pharmaceuticals, Inc.
Biotechnology Research
Cambridge, MA 5,632 followers
Transformation in Sight
About us
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
- Website
-
http://www.alkeuspharma.com
External link for Alkeus Pharmaceuticals, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, MA
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Biopharmaceuticals, Rare Disease, Inherited Retinal Disorders, Genetic Diseases, Retina, and Ophthalmology
Locations
-
Get directions
.
Cambridge, MA, US
Employees at Alkeus Pharmaceuticals, Inc.
Updates
-
Interim data from our TEASE-3 trial were presented today at the 42nd American Society of Retina Specialists (ASRS) Annual Scientific Meeting. Learn more: https://lnkd.in/eyywus9s #AlkeusPharma #Stargardt #breakthrough #ophthalmology
-
We're #hiring a new Director of Strategic Planning in Cambridge, Massachusetts. Apply today or share this post with your network.
-
Tamara Dillon joins the formidable Alkeus team, elevating HR to its correct success-predicting position on the executive team. Nothing succeeds unless the team succeeeds. So great to have Tamara on board.
We are thrilled to share that Tamara Dillon has joined our team as Chief Human Resources Officer. She brings extensive leadership experience and a proven track record of successfully driving organizational growth, talent management and cultural transformation. Welcome Tamara! Learn more: https://lnkd.in/eSaRaenX #AlkeusPharma #culture #biotechnews
-
-
We are thrilled to share that Tamara Dillon has joined our team as Chief Human Resources Officer. She brings extensive leadership experience and a proven track record of successfully driving organizational growth, talent management and cultural transformation. Welcome Tamara! Learn more: https://lnkd.in/eSaRaenX #AlkeusPharma #culture #biotechnews
-
-
Meet Sam, a successful podcast host living with Stargardt disease. His resilience and determination are an inspiration. Learn more about his story: https://lnkd.in/eHygrpDu #stargardt #AlkeusPharma #inspiration #YourNorthStarg #patientvoices
-
We're #hiring a new Director, Clinical Quality in Cambridge, Massachusetts. Apply today or share this post with your network.
-
DYK that Stargardt disease is the most common form of inherited macular degeneration? Stargardt, which affects about 30,000 people in the U.S., leads to vision loss, usually starting in childhood or adolescence. Learn more: https://lnkd.in/etdfKz2G #Stargardt #YourNorhStarg #AlkeusPharma
-
-
Exciting news today: Accomplished biotech leader Michel Dahan has joined Alkeus as our President and CEO. Welcome to the team Michel! For more details, check out the press release here: https://lnkd.in/e6zFcCiG #biotechnews #alkeuspharma #stargardt #CEO
-
-
Jack navigates each day with optimism and his trusted guide dog by his side. Hear more about Jack’s inspiring journey living with Stargardt disease here: https://lnkd.in/eHygrpDu #alkeuspharma #stargardt #YourNorthStarg #patientvoices